- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 37/06 - Immunosuppressants, e.g. drugs for graft rejection
Patent holdings for IPC class A61P 37/06
Total number of patents in this class: 7124
10-year publication summary
|
96
|
135
|
244
|
430
|
347
|
515
|
591
|
624
|
654
|
466
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10721 |
111 |
| The Regents of the University of California | 20108 |
74 |
| Chugai Seiyaku Kabushiki Kaisha | 1370 |
55 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
52 |
| F. Hoffmann-La Roche AG | 7948 |
45 |
| Selecta Biosciences, Inc. | 189 |
40 |
| Bristol-myers Squibb Company | 4849 |
39 |
| Janssen Biotech, Inc. | 1561 |
38 |
| Ono Pharmaceutical Co., Ltd. | 431 |
37 |
| Genentech, Inc. | 4009 |
36 |
| Takeda Pharmaceutical Company Limited | 2710 |
36 |
| Regeneron Pharmaceuticals, Inc. | 4355 |
36 |
| Astellas Pharma Inc. | 1087 |
35 |
| Eli Lilly and Company | 3902 |
35 |
| Daiichi Sankyo Company, Limited | 1877 |
33 |
| The Board of Trustees of the Leland Stanford Junior University | 6476 |
32 |
| Incyte Corporation | 1025 |
31 |
| Osaka University | 3397 |
31 |
| The General Hospital Corporation | 4770 |
30 |
| The Trustees of the University of Pennsylvania | 4349 |
27 |
| Other owners | 6271 |